**BREAKING NEWS AND CURRENT CASES**

METFORMIN FDA RECALL IS EXPANDED ON 11/3/2020

On November 2nd and 3rd the Food and Drug Administration announced the additional recall of two batches of Metformin. The newest recalls are for Metformin HCI extended release tablets (USP 500 mg and USP 750 mg) manufactured by Nostrum Laboratories due to NDMA levels above the acceptable daily intake limit. Our Metformin Attorneys are following these recent developments and assisting potential clients with information gathering and evaluation for potential claims. Learn More By Reviewing the Information on our Metformin Lawsuits Page.

Contact Us For A Metformin Case Evaluation